Eli Lilly lifts 2020 profit view as coronavirus lockdowns fuel profit beat

Eli Lilly and Co beat quarterly profit estimates and raised the top-end of its 2020 earnings forecast on Thursday, benefiting from customers stockpiling on medicines such as its diabetes treatment Trulicity amid the coronavirus pandemic.

…read more

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

Source:: Reuters – Business News